Search results
Results from the WOW.Com Content Network
Amoebiasis, or amoebic dysentery, is an infection of the intestines caused by a parasitic amoeba Entamoeba histolytica. [3] [4] Amoebiasis can be present with no, mild, or severe symptoms. [2] Symptoms may include lethargy, loss of weight, colonic ulcerations, abdominal pain, diarrhea, or bloody diarrhea.
Edible vaccines are subunit vaccines; they contain a antigen proteins for a pathogen but lack the genes for the full pathogen to form. [ 2 ] [ 3 ] The first steps in making an edible vaccine is the identification, isolation, and characterization of a pathogenic antigen. [ 1 ]
Delivery of Yakult drinks on a Yakult-branded bicycle in Fukushima City, Japan, 2009. In 2006, a panel appointed by the Netherlands Nutrition Center (Voedingscentrum) to evaluate a marketing request by Yakult found sufficient evidence to justify claims that drinking at least one bottle of Yakult per day might help improve bowel movements for people who tend to be constipated and might help ...
For example, Shigella is a longstanding World Health Organization (WHO) target for vaccine development, and sharp declines in age-specific diarrhea/dysentery attack rates for this pathogen indicate that natural immunity does develop following exposure; thus, vaccination to prevent this disease should be feasible. The development of vaccines ...
Antiprotozoals are used to treat protozoal infections, which include amebiasis, giardiasis, cryptosporidiosis, microsporidiosis, malaria, babesiosis, trypanosomiasis, Chagas disease, leishmaniasis, and toxoplasmosis. [6] Currently, many of the treatments for these infections are limited by their toxicity. [7]
Yakult Honsha is a multinational corporation that sells various other products and owns the Tokyo Yakult Swallows baseball team, in addition to the Roaring Raymonds. The company regularly promotes what the Financial Times called its "idiosyncratic philosophy of 'Shirota-ism,'" namely that it should sell its products at an affordable price, and ...
It is an antimicrobial used to treat intestinal parasitic infections such as cryptosporidiosis [8] and amoebiasis, [9] and other diseases such as leishmaniasis. [10] Paromomycin was demonstrated to be effective against cutaneous leishmaniasis in clinical studies in the USSR in the 1960s, and in trials with visceral leishmaniasis in the early ...
Entamoeba histolytica is the pathogen responsible for invasive 'amoebiasis' (which includes amoebic dysentery and amoebic liver abscesses). Others such as Entamoeba coli (not to be confused with Escherichia coli ) and Entamoeba dispar [ 3 ] are harmless.